Pricing Log in Create free account

Ovid Therapeutics (OVID) vs SL SCIENCE HLDG (SLBT)

Ovid Therapeutics and SL SCIENCE HLDG are both Biotechnology companies. Ovid Therapeutics and SL SCIENCE HLDG are of similar size ($504.7M and $503.9M). Across the 3 metrics below, SL SCIENCE HLDG leads on 2 and Ovid Therapeutics on 1.

Valuation

Metric OVID SLBT Biotechnology median
P/E n/m — 10.60
P/S 72.14 — 9.40
P/B 2.70 n/m 2.13
Price to free cash flow n/m — 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 58.65 n/m 9.02
Earnings yield (7.85%) — (32.88%)
Free cash flow yield (9.69%) — (23.13%)

Profitability

Metric OVID SLBT Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (742.97%) — 0.00%
Net margin (439.11%) — 0.00%
Free cash flow margin (697.30%) — 0.00%
Return on equity (25.97%) — (51.96%)
Return on assets (22.30%) — (46.06%)
Return on invested capital (35.11%) 0.00% 0.00%

Growth

Metric OVID SLBT Biotechnology median
Revenue growth (TTM) 1,333.39% — 6.76%
EPS growth (last fiscal year) 37.84% — 29.88%
Revenue growth, 5-year CAGR (10.48%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric OVID SLBT Biotechnology median
Debt to equity 0.05 0.00 0.00
Current ratio 12.39 4.44 4.97
Net debt to EBITDA 1.37 — 1.01

Dividend

Metric OVID SLBT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric OVID SLBT Biotechnology median
Market cap 503.87m 504.74m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack